Meeting
2024 ASCO Annual Meeting
Precision oncology for rare gynecologic malignancies: Integrating molecular tumor boards and real-time treatment matching.
Authors
Brooke Grant
Princess Margaret Cancer Centre, Toronto, ON, Canada
Brooke Grant , Anmol Kaur Pannu , Valerie Bowering , Ana Veneziani , Pamela Soberanis Pina , Eduardo Gonzalez-Ochoa , Husam Alqaisi , Vikas Garg , Dina Braik , Anjelica Hodgson , Marjan Rouzbahman , Tanya Chawla , Anthony Msan , Steven Siman , Ian King , Tracy Stockley , Robert C Grant , Neesha C. Dhani , Stephanie Lheureux , Amit M. Oza
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gynecologic Cancer
Track
Gynecologic Cancer
Sub Track
Biologic Correlates
Citation
J Clin Oncol 42, 2024 (suppl 16; abstr 5523)
DOI
10.1200/JCO.2024.42.16_suppl.5523
Abstract #
5523
Poster Bd #
394
Abstract Disclosures
Similar Posters
Poster
2014 ASCO Annual Meeting
Molecular profiling in gynecologic cancer and matched targeted therapy: A step toward improving personalized medicine.
First Author: Ana C. Garrido-Castro
Poster
2023 ASCO Quality Care Symposium
Innovative biomarker testing initiative in a community oncology setting.
First Author: Lorraine Brisbin
Poster
2022 ASCO Annual Meeting
Implementation of a precision medicine thoracic (PREDICT) service using reflex testing in a large academic-community practice network.
First Author: Debora S. Bruno
Poster
2022 ASCO Annual Meeting
Biomarker-directed therapy in black and white men with metastatic castration-resistant prostate cancer (mCRPC).
First Author: Clara Hwang